The main goal of this project is to understand the role of the B cell surface protein CD72 in the regulation of B cell development and responsiveness. These studies will make extensive use of CD72-deficient mutant mice, which have hyperresponsive B cells and defects in B cell development and selection.
The first aim i s to further define the mechanisms by which CD72 regulates responsiveness and development by examination of functional interactions between CD72 and other surface proteins and signaling molecules. These studies will take advantage of a number of other mutant mouse strains lacking proteins (e.g., CD 19, CD22, Lyn) that appear to have similar or opposing functions to those of CD72 and that may interact directly or indirectly with CD72 signaling. CD72 signaling will be examined in such mutant mice. The effects of CD72 deficiency upon signaling involving these other regulatory proteins will also be assessed. Mice doubly deficient for CD72 and these other proteins will be generated and their phenotype examined to further elucidate the interactions between CD72 and other negative or positive regulators of B cell responsiveness.
The second aim i s to define the role of specific motifs in the CD72 cytoplasmic tail in regulating B cell maturation and responsiveness. This will be done by generation of mice expressing CD72 in which particular amino acids thought to be involved in signaling have been mutated. The resultant mice will be characterized to see which of the defects present in CD72-deficient mice are still present or are restored to normal in these new mutants.
The third aim i s to study the mechanism(s) by which lack of CD72 alters tolerance using CD72-deficient mice that are transgenic for a specific B cell receptor (BCR) and either express or do not express the specific antigen recognized by that BCR.
The final aim i s to determine how interactions between CD72 and the semaphorin protein CD 100 regulate B cell responsiveness and development using mouse model systems overexpressing or lacking each of these proteins. These studies will be important for understanding the mechanisms regulating B cell development, tolerance and autoimmunity.

National Institute of Health (NIH)
National Cancer Institute (NCI)
Research Project (R01)
Project #
Application #
Study Section
Allergy and Immunology Study Section (ALY)
Program Officer
Mccarthy, Susan A
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Stanford University
Internal Medicine/Medicine
Schools of Medicine
United States
Zip Code
Oliveira, Marta I; Gonçalves, Carine M; Pinto, Mafalda et al. (2012) CD6 attenuates early and late signaling events, setting thresholds for T-cell activation. Eur J Immunol 42:195-205
Li, Daniel Hsieh-Hsin; Winslow, Monte M; Cao, Thai M et al. (2008) Modulation of peripheral B cell tolerance by CD72 in a murine model. Arthritis Rheum 58:3192-204
Castro, Monica A A; Oliveira, Marta I; Nunes, Raquel J et al. (2007) Extracellular isoforms of CD6 generated by alternative splicing regulate targeting of CD6 to the immunological synapse. J Immunol 178:4351-61
Li, Yi-Yang Yvonne; Yang, Yang; Bao, Ming et al. (2006) Mouse splenic B lymphocyte activation using different activation stimuli induces in vitro splicing of tumor necrosis factor-alpha nuclear pre-mRNA. Mol Immunol 43:613-22
Li, Daniel H; Tung, James W; Tarner, Ingo H et al. (2006) CD72 down-modulates BCR-induced signal transduction and diminishes survival in primary mature B lymphocytes. J Immunol 176:5321-8
Baba, Takeshi; Fusaki, Noemi; Aoyama, Akitoshi et al. (2005) Dual regulation of BCR-mediated growth inhibition signaling by CD72. Eur J Immunol 35:1634-42
Kumanogoh, Atsushi; Shikina, Takashi; Watanabe, Chie et al. (2005) Requirement for CD100-CD72 interactions in fine-tuning of B-cell antigen receptor signaling and homeostatic maintenance of the B-cell compartment. Int Immunol 17:1277-82
Singer, Nora G; Fox, David A; Haqqi, Tariq M et al. (2002) CD6: expression during development, apoptosis and selection of human and mouse thymocytes. Int Immunol 14:585-97
Parnes, J R; Pan, C (2000) CD72, a negative regulator of B-cell responsiveness. Immunol Rev 176:75-85
Shi, W; Kumanogoh, A; Watanabe, C et al. (2000) The class IV semaphorin CD100 plays nonredundant roles in the immune system: defective B and T cell activation in CD100-deficient mice. Immunity 13:633-42

Showing the most recent 10 out of 18 publications